Market closed

Terns Pharmaceuticals/TERN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Terns Pharmaceuticals

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

Ticker

TERN
Trading on

Industry

Pharmaceuticals

Employees

66

TERN Metrics

BasicAdvanced
$625M
Market cap
-
P/E ratio
-$1.31
EPS
-0.38
Beta
-
Dividend rate
$625M
-0.38
$10.03
$3.26
2.8M
21.017
20.566
0.114
-25.99%
-38.92%
2.38
2.38
-6.853
6.69%
-27.18%

What the Analysts think about TERN

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Terns Pharmaceuticals stock.

TERN Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

TERN Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy TERN

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Terns Pharmaceuticals stock?

Terns Pharmaceuticals (TERN) has a market cap of $625M as of October 11, 2024.

What is the P/E ratio for Terns Pharmaceuticals stock?

The price to earnings (P/E) ratio for Terns Pharmaceuticals (TERN) stock is 0 as of October 11, 2024.

Does Terns Pharmaceuticals stock pay dividends?

No, Terns Pharmaceuticals (TERN) stock does not pay dividends to its shareholders as of October 11, 2024.

When is the next Terns Pharmaceuticals dividend payment date?

Terns Pharmaceuticals (TERN) stock does not pay dividends to its shareholders.

What is the beta indicator for Terns Pharmaceuticals?

Terns Pharmaceuticals (TERN) has a beta rating of -0.38. This means that it has an inverse relation to market volatility.